Optune
Showing 1 - 25 of 39
Malignant Glioma, Ependymoma Trial in United States (Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields))
Active, not recruiting
- Malignant Glioma
- +2 more
- Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields)
- Concurrent Optune and RT followed by Optune System alone
-
Los Angeles, California
- +8 more
Jan 17, 2023
High Grade Glioma, Ependymoma Trial in Orlando, Hackensack (Optune NovoTTF-200A System)
Recruiting
- High Grade Glioma
- Ependymoma
- Optune NovoTTF-200A System
-
Orlando, Florida
- +1 more
Aug 12, 2022
Glioblastoma, Glioblastoma, WHO Grade IV Trial in Gainesville (Temozolomide (TMZ), Optune System, Pembrolizumab)
Active, not recruiting
- Glioblastoma
- Glioblastoma, WHO Grade IV
- Temozolomide (TMZ)
- +2 more
-
Gainesville, FloridaUniversity of Florida Health
Aug 22, 2022
Brain Cancer Trial in United States (Optune (NovoTTF-100A))
Active, not recruiting
- Brain Cancer
- Optune (NovoTTF-100A)
-
Los Angeles, California
- +8 more
Jul 1, 2022
Astrocytoma, Grade II, Astrocytoma, Grade III Trial in United States (TTFields with adjuvant temozolomide)
Terminated
- Astrocytoma, Grade II
- Astrocytoma, Grade III
- TTFields with adjuvant temozolomide
-
Gainesville, Florida
- +4 more
Aug 26, 2021
Glioma Trial in Atlanta (Optune device)
Recruiting
- Glioma
- Optune device
-
Atlanta, Georgia
- +2 more
May 12, 2022
Glioblastoma Multiforme Trial in Prague (TTFields)
Recruiting
- Glioblastoma Multiforme
- TTFields
-
Prague, CzechiaNemocnice Na Homolce
Aug 30, 2021
Glioblastoma, Newly Diagnosed Glioblastoma Trial in Stanford (device, drug, radiation)
Recruiting
- Glioblastoma
- Newly Diagnosed Glioblastoma
- Optune
- +3 more
-
Stanford, CaliforniaStanford University
Aug 1, 2022
Uveal Melanoma Trial in Scottsdale (Novocure Optune, Opdivo, Yervoy)
Recruiting
- Uveal Melanoma
- Novocure Optune
- +2 more
-
Scottsdale, ArizonaHonorHealth Research Institute
Mar 21, 2022
Glioblastoma, Glioma, Gliosarcoma Trial in United States (Bevacizumab, TTFields Therapy)
Terminated
- Glioblastoma
- +2 more
- Bevacizumab
- TTFields Therapy
-
La Jolla, California
- +10 more
May 12, 2021
Glioblastoma Trial in Philadelphia (drug, radiation, device, procedure)
Recruiting
- Glioblastoma
- Temozolomide
- +3 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jun 3, 2021
Glioblastoma, Brain Tumors Trial in Gainesville, Saint Louis (device, procedure, genetic)
Terminated
- Glioblastoma
- Brain Neoplasms
- NovoTTF-100A
- +2 more
-
Gainesville, Florida
- +1 more
Nov 19, 2021
CNS Tumors, Primary Trial (Optune TTF device)
Withdrawn
- Central Nervous System Neoplasms, Primary
- Optune TTF device
- (no location specified)
Aug 31, 2020
Glioblastoma, Recurrent Glioblastoma, GBM Trial in Philadelphia (drug, device, procedure)
Recruiting
- Glioblastoma
- +2 more
- Niraparib
- +2 more
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Jul 16, 2021
Glioblastoma, Adult Trial in Hackensack (device, drug, radiation)
Active, not recruiting
- Glioblastoma, Adult
- NovoTTF-200A
- +2 more
-
Hackensack, New JerseyJohn Theurer Cancer Center at Hackensack University Medical Cent
Oct 7, 2021
Glioblastoma Trial (TTFields)
Not yet recruiting
- Glioblastoma
- TTFields
- (no location specified)
Nov 15, 2023
Glioblastoma Trial in Aarhus C (Optune, Craniectomy)
Completed
- Glioblastoma
- Optune
- Craniectomy
-
Aarhus C, Aarhus, DenmarkAarhus University Hospital
Nov 25, 2019
GBM, Glioma Glioblastoma Multiforme, Tumor, Brain Trial (Whole Brain Spectroscopy Imaging Array Mapping Layout)
Recruiting
- GBM
- +2 more
- Whole Brain Spectroscopy Imaging Array Mapping Layout
-
Philadelphia, Pennsylvania
- +1 more
Jan 19, 2023
Anaplastic Astrocytoma, Glioblastoma, Oligodendroglioma Trial (drug, device, other, radiation, procedure, biological)
Withdrawn
- Anaplastic Astrocytoma
- +3 more
- Extended Release Flucytosine
- +7 more
- (no location specified)
Mar 20, 2020
Quality of Life of Glioblastoma Treated With Tumor-Treating
Completed
- Malignant Glioma
- NovoTTF
-
Durham, North CarolinaThe Preston Robert Tisch Brain Tumor Center at Duke
Jun 7, 2021
NovoTTF Treatment Signatures in Glioblastoma Patients at Autopsy
Recruiting
- Glioblastoma
- Tumor samples from patients treated with TTFields at initial diagnosis.
- Tumor samples from patients treated with TTFields at tumor recurrence.
-
Milwaukee, WisconsinFroedtert & the Medical College of Wisconsin
Feb 9, 2022
Newly Diagnosed Glioblastoma in Patients =70 Years Trial in Heidelberg (TTFields)
Suspended
- Newly Diagnosed Glioblastoma in Patients ≥70 Years
- TTFields
-
Heidelberg, GermanyUniversity Hospital of Heidelberg, Radiation Oncology
Sep 28, 2021
Gliosarcoma, MGMT-Unmethylated Glioblastoma Trial in United States (biological, device, other, radiation, drug)
Suspended
- Gliosarcoma
- MGMT-Unmethylated Glioblastoma
- Ipilimumab
- +6 more
-
Birmingham, Alabama
- +285 more
Aug 24, 2022